325414 — Biological Product (except Diagnostic) Manufacturing
NAICS 2022 325414 (Biological Product (except Diagnostic) Manufacturing) classifies within economic division 21 (Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.
U.S. Census Bureau • v2022
Pharmaceutical and Medicine Manufacturing
ISIC 2100
MCC 5122
Activity Scope, Operators & Exclusions
Who Uses This Code & Typical Business Models
- Active pharmaceutical ingredient (API) and finished drug makers
- Vaccine, biologic, serum, and diagnostic preparation labs
- Veterinary medicine and medicated surgical dressing manufacturers
This Class Includes
1- This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
This Class Excludes (Cross-References)
0—
Legislation, Licensing, Incorporation & Tax Framework
Governing Statutes & Regulations
Mandatory Permits, Licenses & Authorities
- TİTCK Manufacturing Authorization, Good Manufacturing Practice (GMP) Certificate, and Drug Marketing Authorizations
- İTS serialization integration & mandatory Qualified Person (Mesul Müdür)
- Ministry of Agriculture Veterinary Drug License for 21.20 animal formulations
Incorporation Route & Chamber Registration
- EU NACE Rev. 2.1 Framework
- Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
- United States (IRS / SBA / NAICS)
- Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization.
- United Kingdom (Companies House / HMRC)
- Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.
VAT, Withholding & Statutory Incentives
- Licensed pharmaceuticals carry 10% reduced VAT in Turkey.
- Classified as High-Technology Manufacturing: qualifies for KOSGEB Business Dev grants, Law 5746 R&D Center deductions, and Priority/Strategic Investment Incentives.
Cross-Border Regulatory Frameworks (EU / US / UK)
Chamber of Industry / Commerce + Industrial Registry (Capital Company required) — JSC/LLC structure mandatory for GMP pharmaceutical manufacturing.
Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
Classification Boundaries & Audit Risks
- Dietary supplements and vitamins belong in Div. 10 (10.89) under Food Law, not Div. 21 drugs.
- Non-medicated medical devices and surgical instruments sit in Div. 32 (32.50).
Global Classification Passport
Verified structural and concordance mappings across EU, US, UK, UN, and national registries.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Payment Processing & ISO 18245 MCC Profile
Visa / Mastercard ISO 18245Strictly underwritten: non-OTC pharmaceuticals require pharmacy licensing and Card Brand high-risk registration.
Critical Distinctions & Sibling Codes
325411 — Medicinal and Botanical Manufacturing
This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading...
325412 — Pharmaceutical Preparation Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such...
325413 — In-Vitro Diagnostic Substance Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for di...
Classification Hierarchy & Data Export
- 31-33 Manufacturing
- 325 Chemical Manufacturing
- 3254 Pharmaceutical and Medicine Manufacturing
- 32541 Pharmaceutical and Medicine Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
Frequently Asked Questions
What business activities and models fall under NAICS 2022 325414?
325414 (Biological Product (except Diagnostic) Manufacturing): This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).. Typical operators: Active pharmaceutical ingredient (API) and finished drug makers; Vaccine, biologic, serum, and diagnostic preparation labs.
What regulatory licensing and tax rules apply to 325414 across EU, US, UK, or Turkey?
EU: Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization. US: Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization. UK: Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.
What are the international classification equivalents and MCC code for 325414?
Verified concordance for 325414: UN ISIC Rev. 5: 2100 • Payment MCC 5122 (Drugs, Drug Proprietaries and Druggists Sundries).